EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Supportive Care in Multiple Myeloma: Evidence-Based Recommendations From the Intergroupe Francophone du Myélome (IFM)

IFM Supportive Care Working Group, Laurent Frenzel, Pascal Godmer, Alexis Talbot, Cécile Sonntag, Stéphanie Harel, Thomas Chalopin, Salomon Manier, Cyrille Hulin, Thierry Facon, Lionel Karlin, Jill Corre und 10 weitere

Clinical Lymphoma Myeloma and Leukemia · 2026-11 · 26 (11) · e1366-e1379

DOI: 10.1016/j.clml.2026.09.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-11. Verfasst von IFM Supportive Care Working Group und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Necker University Hospital, AP-HP, Paris, France; Benign Hematology Unit, Memorial Sloan Kettering Cancer Center, New York,…. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a largely incurable plasma cell malignancy in which disease- and treatment-related complications substantially impair quality of life and survival, making supportive care a central determinant of outcome. This review presents unified, evidence-based recommendations from the Intergroupe Francophone du Myélome across 7 domains of supportive care and their implications for contemporary practice, including the era of T-cell-redirecting immunotherapy. With the advent of highly effective induction regimens, autologous stem cell transplantation, immunomodulatory drugs, proteasome inhibitors, anti-CD38 monoclonal antibodies, bispecific antibodies (BsAbs), and chimeric antigen receptor T-cell (CAR-T) therapies, the prevention and management of treatment-emergent toxicities and disease-related sequelae have become increasingly complex. Synthesizing a structured review of the literature, international guidelines, and formal expert consensus, we provide practical recommendations for (1) venous thromboembolism prophylaxis, (2) prevention of skeletal-related events with bone-modifying agents, (3) prevention of infectious complications, (4) vaccination, (5) management of MM-related anemia with erythropoiesis-stimulating agents, (6) adapted physical activity, and (7) practical guidance for the management of treatment-emergent peripheral neuropathy, with particular attention to the specific challenges introduced by BsAbs and CAR-T therapy. By consolidating these 7 domains into a single framework applicable across all lines of therapy, from first-line treatment to relapsed/refractory disease, this review offers a pragmatic reference intended to standardize and improve supportive care and, ultimately, patient outcomes and health-related quality of life in MM. Positions that deliberately differ from other international guidelines-notably those of the International Myeloma Working Group-are explicitly identified and justified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansQuality of LifePractice Guidelines as TopicEvidence-Based Medicine

Stichwörter der Autor:innen

Adapted physical activityBone diseaseInfection preventionThromboprophylaxisVaccination

Autor:innen und Institutionen

  • Department of Hematology, Necker University Hospital, AP-HP, Paris, France; Benign Hematology Unit, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: laurent.frenzel@aphp.fr.
  • Department of Hematology, Centre Hospitalier Bretagne Atlantique, Vannes, France.
  • Inserm UMR 1342, Institut de recherche Saint Louis Université Paris Cité, Paris, France; Department of Immuno-Hematology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Department of Hematology, Strasbourg University Hospital, Strasbourg, France.
  • Department of Hematology, Tours University Hospital, Tours, France.
  • Department of Hematology, Lille University Hospital, Lille, France.

Zitieren

APA

IFM Supportive Care Working Group, Frenzel, L., Godmer, P., Talbot, A., Sonntag, C., Harel, S., Chalopin, T., Manier, S., Hulin, C., Facon, T., Karlin, L., Corre, J., Moreau, P., Touzeau, C., Leleu, X., Decaux, O., Arnulf, B., Louni, C., Mohty, M., …, & Roussel, M. (2026). Supportive Care in Multiple Myeloma: Evidence-Based Recommendations From the Intergroupe Francophone du Myélome (IFM). Clinical Lymphoma Myeloma and Leukemia, 26(11), e1366-e1379. https://doi.org/10.1016/j.clml.2026.09.008

Vancouver

IFM Supportive Care Working Group, Frenzel L, Godmer P, Talbot A, Sonntag C, Harel S, et al. Supportive Care in Multiple Myeloma: Evidence-Based Recommendations From the Intergroupe Francophone du Myélome (IFM). Clinical Lymphoma Myeloma and Leukemia. 2026;26(11):e1366-e1379. doi:10.1016/j.clml.2026.09.008

BibTeX
@article{IFMSupportiveCareWorkingGroup2026,
  author = {IFM Supportive Care Working Group, IFM Supportive Care Working Group and Frenzel, Laurent and Godmer, Pascal and Talbot, Alexis and Sonntag, Cécile and Harel, Stéphanie and Chalopin, Thomas and Manier, Salomon and Hulin, Cyrille and Facon, Thierry and Karlin, Lionel and Corre, Jill and Moreau, Philippe and Touzeau, Cyrille and Leleu, Xavier and Decaux, Olivier and Arnulf, Bertrand and Louni, Chanaz and Mohty, Mohamad and Perrot, Aurore and Chalayer, Emilie and Roussel, Murielle},
  title = {Supportive Care in Multiple Myeloma: Evidence-Based Recommendations From the Intergroupe Francophone du Myélome (IFM)},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  volume = {26},
  number = {11},
  pages = {e1366--e1379},
  doi = {10.1016/j.clml.2026.09.008}
}
Kostenlos starten →